A severe case of tetracycline-induced intracranial  hypertension

Anders Vedel Holst; Patricia Louise Danielsen; Bertil Romner

doi:10.4081/dr.2011.e1

A severe case of tetracycline-induced intracranial hypertension

https://doi.org/10.4081/dr.2011.e1

PDF HTML

Vol. 3 No. 1 (2011)

Submitted: 27 September 2010
Accepted: 18 October 2010

Published: 31 January 2011

Tetracykline, intracranial hypertension

Abstract Views: 5796

PDF: 854
HTML: 865

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Anders Vedel Holst Department of Neurosurgery, Denmark.
Patricia Louise Danielsen
patriciadanielsen@yahoo.dk
Department of Dermatology, Bispebjerg Hospital, Denmark, Denmark.
Bertil Romner Department of Neurosurgery, Denmark.

Tetracykline is a first-line treatment of the common skin disorder acne vulgaris. A rare side effect of tetracycline treatment is intracranial hypertension also called pseudotumor cerebri (PTC). We report a severe case of PTC with cranial nerve palsy and visual loss in a 16 year old girl following acne vulgaris treatment with tetracycline.

Supporting Agencies

Holst, A. V., Danielsen, P. L., & Romner, B. (2011). A severe case of tetracycline-induced intracranial hypertension. Dermatology Reports, 3(1), e1. https://doi.org/10.4081/dr.2011.e1